Cite
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study).
MLA
Jones, T.Hugh, et al. “Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study).” Diabetes Care, vol. 34, no. 4, Apr. 2011, pp. 828–37. EBSCOhost, https://doi.org/10.2337/dc10-1233.
APA
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., & Channer, K. S. (2011). Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care, 34(4), 828–837. https://doi.org/10.2337/dc10-1233
Chicago
Jones, T. Hugh, Stefan Arver, Hermann M. Behre, Jacques Buvat, Eric Meuleman, Ignacio Moncada, Antonio Martin Morales, et al. 2011. “Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study).” Diabetes Care 34 (4): 828–37. doi:10.2337/dc10-1233.